REGULATORYPulse Biosciences opens $75 million at-the-market shelf with Mizuho as dilution risk lingersCRYPTOMARA's record output fails to prevent Q2 loss as Bitcoin price falls 28%EARNINGSHaynes King gives Carolina a 33-30 win and a legitimate quarterback storyline entering training campREGULATORY8x8 shareholders back the full ballot, but the equity plan and chair vote tell a different storyREGULATORYFive patents, one Nasdaq problem: the case for Caring Brands rests on more than IPWORLDSam Acho makes the case for athlete-led civility, and names the cost of getting it wrongREGULATORYPulse Biosciences opens $75 million at-the-market shelf with Mizuho as dilution risk lingersCRYPTOMARA's record output fails to prevent Q2 loss as Bitcoin price falls 28%EARNINGSHaynes King gives Carolina a 33-30 win and a legitimate quarterback storyline entering training campREGULATORY8x8 shareholders back the full ballot, but the equity plan and chair vote tell a different storyREGULATORYFive patents, one Nasdaq problem: the case for Caring Brands rests on more than IPWORLDSam Acho makes the case for athlete-led civility, and names the cost of getting it wrong